About Medicinal Genomics
Medicinal Genomics is a company based in Woburn (United States) founded in 2011 was acquired by Courtagen in January 2012. Medicinal Genomics has raised $7.69 million across 2 funding rounds from investors including Courtagen. Medicinal Genomics offers products and services including PathoSEEK® qPCR Detection Assays, MaGiC Lysis Kits, FemINDICAtor® qPCR Plant Gender Detection Assay, and SenSATIVAx® DNA Purification Kits. Medicinal Genomics operates in a competitive market with competitors including Benson Hill, Cibus, Pairwise, Inari and Ceres, among others.
- Headquarter Woburn, United States
-
Sectors
HealthcareAgriculture
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Medicinal Genomics Corps
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Medicinal Genomics
Medicinal Genomics offers a comprehensive portfolio of products and services, including PathoSEEK® qPCR Detection Assays, MaGiC Lysis Kits, FemINDICAtor® qPCR Plant Gender Detection Assay, and SenSATIVAx® DNA Purification Kits.
Detects pathogens in cannabis plants using qPCR technology.
Prepares samples for genomic analysis in plant testing.
Identifies plant gender early to optimize breeding processes.
Purifies DNA for accurate microbial and genetic testing.
People of Medicinal Genomics
Unlock access to complete
Sales and Marketing
4 people
Operations Team
2 people
Leadership Team
2 people
Finance and Accounting
1 people
Unlock access to complete
Funding Insights of Medicinal Genomics
Medicinal Genomics has successfully raised a total of $7.69M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $2.68 million completed in April 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Medicinal Genomics
Medicinal Genomics has secured backing from 1 investor. Prominent investors backing the company include Courtagen.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Provides solutions for neurological and metabolic disorders.
|
Locked | Locked | Locked |
Investor details for Medicinal Genomics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Medicinal Genomics
Investment portfolio details for Medicinal Genomics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Medicinal Genomics
Detailed financials for Medicinal Genomics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Medicinal Genomics Comparisons
Peer comparison for Medicinal Genomics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Medicinal Genomics
Medicinal Genomics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Benson Hill, Cibus, Pairwise, Inari and Ceres, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of plant-based food ingredients
|
|
| Locked | Locked | Locked |
Gene editing solutions are provided for agriculture.
|
|
| Locked | Locked | Locked |
New crop varieties are developed using gene-editing for agrigenomics.
|
|
| Locked | Locked | Locked |
Breeding technology is provided by Inari to design seeds.
|
|
| Locked | Locked | Locked |
Beers are produced and branded by Ceres in Italy.
|
|
| Locked | Locked | Locked |
Developer of a predictive breeding platform to identify crop traits and build crop models
|
Detailed competitors of Medicinal Genomics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Medicinal Genomics
Complete news archive for Medicinal Genomics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Medicinal Genomics
Medicinal Genomics was founded in 2011 and raised its 1st funding round 6 years after it was founded.
Medicinal Genomics is headquartered in Woburn, United States. It is registered at Woburn, Massachusetts, United States.
Medicinal Genomics is a funded company, having raised a total of $7.69M across 2 funding rounds to date.
Medicinal Genomics was founded in 2011 and is based in Woburn, United States. Cannabis sequencing services are offered, including a DNA database for the plant. Fingerprinting assays are planned, encompassing DNA purification, gender testing, and microbial testing. These support strain genotyping and sequencing for development in the genomics sector.
Medicinal Genomics's top competitors include Benson Hill, Cibus and Inari.
Medicinal Genomics offers PathoSEEK® qPCR Detection Assays, MaGiC Lysis Kits, FemINDICAtor® qPCR Plant Gender Detection Assay, and SenSATIVAx® DNA Purification Kits.
Medicinal Genomics has 1 investor. Key investors include Courtagen.